Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group-European Academy of Allergy and Clinical Immunology Task Force.

Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group-European Academy of Allergy and Clinical Immunology Task Force.

A Task Force was commissioned collectively by the European Academy of Allergy and Clinical Immunology (EAACI) and the Respiratory Effectiveness Group (REG) to develop a high quality evaluation device for real-life observational analysis to establish high-quality real-life bronchial asthma research that might be thought-about inside future guideline growth.The ensuing REal Life EVidence AssessmeNt Tool (RELEVANT) was achieved by way of an intensive evaluation of present initiatives in this space.

The first model was piloted amongst 9 raters throughout 6 articles; the revised, interim, model underwent in depth testing by 22 reviewers from the EAACI membership and REG collaborator group, resulting in additional revisions and device finalisation. RELEVANT was validated by way of an evaluation of real-life effectiveness research recognized by way of systematic evaluate of Medline and Embase databases and regarding subjects for which real-life research might provide priceless proof complementary to that from randomised managed trials.

The subjects have been chosen by way of a vote amongst Task Force members and associated to the affect of adherence, smoking, inhaler machine and particle measurement on bronchial asthma remedy effectiveness.Although highlighting a basic lack of high-quality real-life effectiveness observational analysis on these clinically vital subjects, the evaluation offered insights into how recognized observational research may inform bronchial asthma pointers builders and clinicians.

Overall, RELEVANT appeared dependable and straightforward to make use of by professional reviewers.Using such high quality appraisal instruments is obligatory to evaluate whether or not particular observational real-life effectiveness research can be utilized to tell guideline growth and/or decision-making in medical observe.

 Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group-European Academy of Allergy and Clinical Immunology Task Force.
Quality standards in respiratory real-life effectiveness analysis: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group-European Academy of Allergy and Clinical Immunology Task Force.

New European Academy of Allergy and Clinical Immunology definition on pollen season mirrors symptom load for grass and birch pollen-induced allergic rhinitis.

BACKGROUND
The use of allergen immunotherapy (AIT) for allergic rhinitis and its medical efficacy in medical trials will depend on the efficient dedication of pollen allergen publicity time durations. We consider pollen information from Germany to look at the new definitions on pollen season and peak pollen interval begin and finish as proposed by the European Academy of Allergy and Clinical Immunology (EAACI) in a just lately printed Position Paper. The goal was to reveal the potential of these definitions to reflect symptom hundreds for grass and birch pollen-induced allergic rhinitis primarily based on real-life information.

FBXW7

MBS395617-01mg 0.1mg
EUR 425

FBXW7

MBS395617-5x01mg 5x0.1mg
EUR 1760

FBXW7

MBS395658-01mg 0.1mg
EUR 425

FBXW7

MBS395658-5x01mg 5x0.1mg
EUR 1760

FBXW7

MBS396427-005mg 0.05mg
EUR 250

FBXW7

MBS396427-5x005mg 5x0.05mg
EUR 975

FBXW7

MBS8535791-01mL 0.1mL
EUR 325

FBXW7

MBS8535791-01mLAF405L 0.1mL(AF405L)
EUR 565

FBXW7

MBS8535791-01mLAF405S 0.1mL(AF405S)
EUR 565

FBXW7

MBS8535791-01mLAF610 0.1mL(AF610)
EUR 565

FBXW7

MBS8535791-01mLAF635 0.1mL(AF635)
EUR 565

FBXW7

MBS8565275-01mL 0.1mL
EUR 345

FBXW7

MBS8565275-01mLAF405L 0.1mL(AF405L)
EUR 565

FBXW7

MBS8565275-01mLAF405S 0.1mL(AF405S)
EUR 565

FBXW7

MBS8565275-01mLAF610 0.1mL(AF610)
EUR 565

FBXW7

MBS8565275-01mLAF635 0.1mL(AF635)
EUR 565

FBXW7

MBS8561548-01mLAF405L 0.1mL(AF405L)
EUR 565

FBXW7

MBS8561548-01mLAF405S 0.1mL(AF405S)
EUR 565

FBXW7

MBS8561548-01mLAF610 0.1mL(AF610)
EUR 565

FBXW7

MBS8561548-01mLAF635 0.1mL(AF635)
EUR 565

FBXW7

MBS8561548-02mL 0.2mL
EUR 345

FBXW7 Antibody

36334 100ul
EUR 319

FBXW7 Antibody

36334-100ul 100ul
EUR 302.4

FBXW7 antibody

70R-6541 50 ug
EUR 467
Description: Rabbit polyclonal FBXW7 antibody raised against the C terminal of FBXW7

FBXW7 Antibody

DF12400 200ul
EUR 420

FBXW7 Antibody

DF12400-100ul 100ul
EUR 168
Description: WB,IHC,IF/ICC

FBXW7 Antibody

DF12400-200ul 200ul
EUR 210
Description: WB,IHC,IF/ICC

FBXW7 Antibody

1-CSB-PA251991
  • Ask for price
  • Ask for price
  • 50ul
  • 100ul
Description: A polyclonal antibody against FBXW7. Recognizes FBXW7 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:10000, IHC:1:100-1:300

Fbxw7 Antibody

CSB-PA851809XA01MO-02mg 0.2mg Ask for price
Description: Recombinant Mus musculus (Mouse) Fbxw7 protein

Fbxw7 Antibody

CSB-PA851809XA01MO-10mg 10mg Ask for price
Description: Recombinant Mus musculus (Mouse) Fbxw7 protein

FBXW7 Antibody

1-CSB-PA822163LA01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against FBXW7. Recognizes FBXW7 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

FBXW7 Antibody

1-CSB-PA623964
  • Ask for price
  • Ask for price
  • 50ul
  • 100ul
Description: A polyclonal antibody against FBXW7. Recognizes FBXW7 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

FBXW7 Antibody

E036334 100μg/100μl
EUR 255
Description: Available in various conjugation types.

FBXW7 Antibody

E95872 100ul
EUR 255
Description: Available in various conjugation types.

FBXW7 Antibody

E309184 200ul
EUR 275
Description: Available in various conjugation types.

FBXW7 antibody

E39-03057 100ug/100ul
EUR 225
Description: Available in various conjugation types.

Fbxw7 Antibody

GWB-MM538G 50ug Ask for price

FBXW7 Antibody

GWB-MQ768C 50ug Ask for price

FBXW7 Antibody

MBS7053017-005mg 0.05mg
EUR 190

FBXW7 Antibody

MBS7053017-01mg 0.1mg
EUR 270

FBXW7 Antibody

MBS7053017-5x01mg 5x0.1mg
EUR 1205

FBXW7 Antibody

MBS7125268-005mL 0.05mL
EUR 190

FBXW7 Antibody

MBS7125268-01mL 0.1mL
EUR 270

FBXW7 Antibody

MBS7125268-5x01mL 5x0.1mL
EUR 1205

FBXW7 Antibody

MBS7125269-005mL 0.05mL
EUR 190

FBXW7 Antibody

MBS7125269-01mL 0.1mL
EUR 270

FBXW7 Antibody

MBS7125269-5x01mL 5x0.1mL
EUR 1205

FBXW7 Antibody

MBS9405881-01mL 0.1mL
EUR 305

FBXW7 Antibody

MBS9405881-5x01mL 5x0.1mL
EUR 1230

FBXW7 Antibody

MBS9603628-01mL 0.1mL
EUR 260

FBXW7 Antibody

MBS9603628-02mL 0.2mL
EUR 305

FBXW7 Antibody

MBS9603628-5x02mL 5x0.2mL
EUR 1220

FBXW7 Rabbit pAb

A5872-100ul 100 ul
EUR 369.6

FBXW7 Rabbit pAb

A5872-200ul 200 ul
EUR 550.8

FBXW7 Rabbit pAb

A5872-20ul 20 ul
EUR 219.6

FBXW7 Rabbit pAb

A5872-50ul 50 ul
EUR 267.6

FBXW7 cDNA Clone

MBS1266040-001mgPlasmid02mLGlycerolStock 0.01mgPlasmid+0.2mLGlycerol-Stock
EUR 670

FBXW7 cDNA Clone

MBS1266040-5x001mgPlasmid5x02mLGlycerolStock 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock
EUR 2970

FBXW7 Rabbit pAb

E45R26174N 50 ul
EUR 297.75

FBXW7 Rabbit pAb

E2505872 100ul
EUR 225
Description: Available in various conjugation types.

FBXW7 Rabbit pAb

MBS8545847-01mL 0.1mL
EUR 305

FBXW7 Rabbit pAb

MBS8545847-01mLAF405L 0.1mL(AF405L)
EUR 565

FBXW7 Rabbit pAb

MBS8545847-01mLAF405S 0.1mL(AF405S)
EUR 565

FBXW7 Rabbit pAb

MBS8545847-01mLAF610 0.1mL(AF610)
EUR 565

FBXW7 Rabbit pAb

MBS8545847-01mLAF635 0.1mL(AF635)
EUR 565

Mouse FBXW7 siRNA

20-abx916668
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

Human FBXW7 siRNA

20-abx916669
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

FBXW7 siRNA (Human)

MBS8222565-15nmol 15nmol
EUR 405

FBXW7 siRNA (Human)

MBS8222565-30nmol 30nmol
EUR 565

FBXW7 siRNA (Human)

MBS8222565-5x30nmol 5x30nmol
EUR 2450

FBXW7 siRNA (Mouse)

MBS8234176-15nmol 15nmol
EUR 405

FBXW7 siRNA (Mouse)

MBS8234176-30nmol 30nmol
EUR 565

FBXW7 siRNA (Mouse)

MBS8234176-5x30nmol 5x30nmol
EUR 2450

anti- FBXW7 antibody

FNab03057 100µg
EUR 702
Description: Antibody raised against FBXW7

FBXW7 cloning plasmid

CSB-CL822163HU-10ug 10ug
EUR 846
Description: A cloning plasmid for the FBXW7 gene.

FBXW7 Blocking Peptide

33R-5108 100 ug
EUR 119
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of FBXW7 antibody, catalog no. 70R-6541

FBXW7 Blocking Peptide

DF12400-BP 1mg
EUR 234

FBXW7 Blocking Peptide

MBS9621105-1mg 1mg
EUR 380

FBXW7 Blocking Peptide

MBS9621105-5x1mg 5x1mg
EUR 1650

Recombinant Human FBXW7

MBS7615750-005mg 0.05mg
EUR 405

Recombinant Human FBXW7

MBS7615750-02mg 0.2mg
EUR 760

Recombinant Human FBXW7

MBS7615750-1mg 1mg
EUR 2175

Recombinant Human FBXW7

MBS7615750-5x1mg 5x1mg
EUR 8410

FBXW7 Polyclonal Antibody

E-AB-14856-120uL 120uL
EUR 240
Description: Unconjugated

FBXW7 Polyclonal Antibody

E-AB-14856-200uL 200uL
EUR 399
Description: Unconjugated

FBXW7 Polyclonal Antibody

E-AB-14856-20uL 20uL
EUR 73
Description: Unconjugated

FBXW7 Polyclonal Antibody

E-AB-14856-60uL 60uL
EUR 143
Description: Unconjugated

FBXW7 Polyclonal Antibody

E-AB-11064-120uL 120uL
EUR 240
Description: Unconjugated

FBXW7 Polyclonal Antibody

E-AB-11064-200uL 200uL
EUR 399
Description: Unconjugated

FBXW7 Polyclonal Antibody

E-AB-11064-20uL 20uL
EUR 73
Description: Unconjugated

FBXW7 Polyclonal Antibody

E-AB-11064-60uL 60uL
EUR 143
Description: Unconjugated

FBXW7 polyclonal antibody

BS70690 50 ul
EUR 358
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

FBXW7 polyclonal antibody

BS90499 50ul
EUR 398
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

FBXW7 Polyclonal Antibody

E-AB-68384-120uL 120uL
EUR 320
Description: Unconjugated

FBXW7 Polyclonal Antibody

E-AB-68384-200uL 200uL
EUR 530
Description: Unconjugated

FBXW7 Polyclonal Antibody

E-AB-68384-60uL 60uL
EUR 200
Description: Unconjugated

FBXW7 Polyclonal Antibody

E-AB-68384-each each Ask for price
Description: Unconjugated

FBXW7 Polyclonal Antibody

MBS2518034-002mL 0.02mL
EUR 135

FBXW7 Polyclonal Antibody

MBS2518034-006mL 0.06mL
EUR 190

FBXW7 Polyclonal Antibody

MBS2518034-012mL 0.12mL
EUR 265

FBXW7 Polyclonal Antibody

MBS2518034-02mL 0.2mL
EUR 415

FBXW7 Polyclonal Antibody

MBS2518034-5x02mL 5x0.2mL
EUR 1835

FBXW7 Polyclonal Antibody

MBS2523340-002mL 0.02mL
EUR 135

FBXW7 Polyclonal Antibody

MBS2523340-006mL 0.06mL
EUR 190

FBXW7 Polyclonal Antibody

MBS2523340-012mL 0.12mL
EUR 265

FBXW7 Polyclonal Antibody

MBS2523340-02mL 0.2mL
EUR 415

FBXW7 Polyclonal Antibody

MBS2523340-5x02mL 5x0.2mL
EUR 1835

FBXW7 Polyclonal Antibody

MBS2540074-006mL 0.06mL
EUR 190

FBXW7 Polyclonal Antibody

MBS2540074-012mL 0.12mL
EUR 265

FBXW7 Polyclonal Antibody

MBS2540074-02mL 0.2mL
EUR 415

FBXW7 Polyclonal Antibody

MBS2540074-5x02mL 5x0.2mL
EUR 1835

FBXW7 Polyclonal Antibody

MBS9128018-002mL 0.02mL
EUR 200

FBXW7 Polyclonal Antibody

MBS9128018-005mL 0.05mL
EUR 255

FBXW7 Polyclonal Antibody

MBS9128018-01mL 0.1mL
EUR 345

FBXW7 Polyclonal Antibody

MBS9128018-02mL 0.2mL
EUR 545

FBXW7 Polyclonal Antibody

MBS9128018-5x02mL 5x0.2mL
EUR 2265

FBXW7 Polyclonal Antibody

RD211064A-120uL 120μL
EUR 360
Description: This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene was previously referred to as FBX30, and belongs to the Fbws class; in addition to an F-box, this protein contains 7 tandem WD40 repeats.

FBXW7 Polyclonal Antibody

RD211064A-200uL 200μL
EUR 630
Description: This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene was previously referred to as FBX30, and belongs to the Fbws class; in addition to an F-box, this protein contains 7 tandem WD40 repeats.

FBXW7 Polyclonal Antibody

RD211064A-20uL 20μL
EUR 109.5
Description: This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene was previously referred to as FBX30, and belongs to the Fbws class; in addition to an F-box, this protein contains 7 tandem WD40 repeats.

FBXW7 Polyclonal Antibody

RD211064A-60uL 60μL
EUR 214.5
Description: This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene was previously referred to as FBX30, and belongs to the Fbws class; in addition to an F-box, this protein contains 7 tandem WD40 repeats.

FBXW7 Polyclonal Antibody

RD77945A-120uL 120μL
EUR 360
Description: This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene was previously referred to as FBX30, and belongs to the Fbws class; in addition to an F-box, this protein contains 7 tandem WD40 repeats.

FBXW7 Polyclonal Antibody

RD77945A-200uL 200μL
EUR 630
Description: This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene was previously referred to as FBX30, and belongs to the Fbws class; in addition to an F-box, this protein contains 7 tandem WD40 repeats.

FBXW7 Polyclonal Antibody

RD77945A-20uL 20μL
EUR 109.5
Description: This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene was previously referred to as FBX30, and belongs to the Fbws class; in addition to an F-box, this protein contains 7 tandem WD40 repeats.

FBXW7 Polyclonal Antibody

RD77945A-60uL 60μL
EUR 214.5
Description: This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene was previously referred to as FBX30, and belongs to the Fbws class; in addition to an F-box, this protein contains 7 tandem WD40 repeats.

FBXW7 Polyclonal Antibody

RD83554A-120uL 120μL
EUR 360
Description: This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene was previously referred to as FBX30, and belongs to the Fbws class; in addition to an F-box, this protein contains 7 tandem WD40 repeats. This protein binds directly to cyclin E and probably targets cyclin E for ubiquitin-mediated degradation. Mutations in this gene are detected in ovarian and breast cancer cell lines, implicating the gene's potential role in the pathogenesis of human cancers. Multiple transcript variants encoding different isoforms have been found for this gene.

FBXW7 Polyclonal Antibody

RD83554A-200uL 200μL
EUR 630
Description: This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene was previously referred to as FBX30, and belongs to the Fbws class; in addition to an F-box, this protein contains 7 tandem WD40 repeats. This protein binds directly to cyclin E and probably targets cyclin E for ubiquitin-mediated degradation. Mutations in this gene are detected in ovarian and breast cancer cell lines, implicating the gene's potential role in the pathogenesis of human cancers. Multiple transcript variants encoding different isoforms have been found for this gene.

FBXW7 Polyclonal Antibody

RD83554A-60uL 60μL
EUR 204
Description: This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene was previously referred to as FBX30, and belongs to the Fbws class; in addition to an F-box, this protein contains 7 tandem WD40 repeats. This protein binds directly to cyclin E and probably targets cyclin E for ubiquitin-mediated degradation. Mutations in this gene are detected in ovarian and breast cancer cell lines, implicating the gene's potential role in the pathogenesis of human cancers. Multiple transcript variants encoding different isoforms have been found for this gene.

pECMV- 3*Flag- FBXW7

PVT10356 2 ug
EUR 361.2

FBXW7 ELISA KIT|Human

EF009598 96 Tests
EUR 826.8

FBXW7 Antibody (N-term)

E45R33093G-1 100 ul
EUR 395

FBXW7 Antibody (N-term)

E45R33093G-4 50 ul
EUR 295

FBXW7 Antibody (N-term)

E45R33122G-1 100 ul
EUR 395

FBXW7 Antibody (N-term)

E45R33122G-4 50 ul
EUR 295

FBXW7 Antibody (N-term)

MBS9204517-008mL 0.08mL
EUR 210

FBXW7 Antibody (N-term)

MBS9204517-04mL 0.4mL
EUR 430

FBXW7 Antibody (N-term)

MBS9204517-5x04mL 5x0.4mL
EUR 1910

FBXW7 Antibody (N-term)

MBS9207621-008mL 0.08mL
EUR 210

FBXW7 Antibody (N-term)

MBS9207621-04mL 0.4mL
EUR 430

FBXW7 Antibody (N-term)

MBS9207621-5x04mL 5x0.4mL
EUR 1910

Mouse FBXW7 shRNA Plasmid

20-abx974100
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Human FBXW7 shRNA Plasmid

20-abx960632
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Human FBXW7 Protein Lysate

MBS8411664-002mg 0.02mg
EUR 545

Human FBXW7 Protein Lysate

MBS8411664-5x002mg 5x0.02mg
EUR 2225

Fbxw7 Peptide - middle region

MBS3228560-01mg 0.1mg
EUR 180

Fbxw7 Peptide - middle region

MBS3228560-5x01mg 5x0.1mg
EUR 730

FBXW7 (NM_001013415) Human Recombinant Protein

E45H30733E1 50 ug
EUR 552.5

Fbxw7 Recombinant Rabbit mAb

BS47455 50 ul
EUR 398
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt.

Fbxw7 Recombinant Rabbit mAb

BS45840 50 ul
EUR 398
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt.

Fbxw7 antibody - middle region

MBS3203593-01mL 0.1mL
EUR 455

Fbxw7 antibody - middle region

MBS3203593-5x01mL 5x0.1mL
EUR 1995

FBXW7 Antibody, HRP conjugated

1-CSB-PA822163LB01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against FBXW7. Recognizes FBXW7 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

FBXW7 Antibody, HRP conjugated

MBS7053018-005mg 0.05mg
EUR 190

FBXW7 Antibody, HRP conjugated

MBS7053018-01mg 0.1mg
EUR 270

FBXW7 Antibody, HRP conjugated

MBS7053018-5x01mg 5x0.1mg
EUR 1205

FBXW7 Antibody, FITC conjugated

1-CSB-PA822163LC01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against FBXW7. Recognizes FBXW7 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

FBXW7 Antibody, FITC conjugated

MBS7053019-005mg 0.05mg
EUR 190

FBXW7 Antibody, FITC conjugated

MBS7053019-01mg 0.1mg
EUR 270

FBXW7 Antibody, FITC conjugated

MBS7053019-5x01mg 5x0.1mg
EUR 1205

OEEG01153-50UG - FBXW7 Peptide

OEEG01153-50UG 50ug
EUR 189

FBXW7 Recombinant Protein (Human)

RP039052 100 ug Ask for price

FBXW7 Recombinant Protein (Mouse)

RP134159 100 ug Ask for price

FBXW7 Recombinant Protein (Mouse)

RP134162 100 ug Ask for price

FBXW7 Recombinant Protein (Mouse)

RP134165 100 ug Ask for price

FBXW7 Rabbit Polyclonal Antibody

54933 100ul
EUR 439

FBXW7 Antibody, Biotin conjugated

1-CSB-PA822163LD01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against FBXW7. Recognizes FBXW7 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA
METHODS
Data coming from 4 pollen monitoring stations in the Berlin and Brandenburg space in Germany and for three years (2014-2016) have been used to analyze the correlation of season definitions, birch and grass pollen counts and complete nasal symptom and mediation scores as reported by sufferers in “Patients Hay fever Diaries” (PHDs). After the identification of pollen durations on the foundation of the EACCI standards, a statistical evaluation was employed, adopted by an in depth graphical investigation.
RESULTS
The evaluation revealed that the definitions of pollen season in addition to peak pollen interval begin and finish as proposed by the EAACI are correlated to symptom hundreds for grass and birch pollen-induced allergic rhinitis reported by sufferers in PHDs.
CONCLUSIONS
Based on our evaluation, the validity of the EAACI definitions on pollen season is confirmed. Their use is advisable in future medical trials on AIT in addition to in each day routine for optimum affected person care.

Antigens

Antigens are defined as substances capable of stimulating the production of antibodies, with which they react specifically. This definition is incomplete since it is well known that antigens can induce cell-mediated immune responses. So antigens are all molecules introduced into the body that can induce an immune response; that is to say the induction of the production of specific immune effectors (humoral or cellular) and to react with these.

antigen is a category of molecules (a molecular species) defined by its antigenic specificity. And, it defines antigenic specificity as the property of a given antigen to combine with a given (usually heterogeneous) population of antibodies. A given antigen can combine with several different or identical antibodies.

Classifications

According to origin

– Xeno-antigen XENO ANTIGENS: these are the antigens present in all individuals of one or more species distinct from that to which the immunized subject belongs.
– Allo antigens (Iso antigens): these are antigens found in a group of individuals of the same species and can induce an immune response in individuals who do not have them.
– Auto antigens: these are the antigens of an individual that can induce an anti-self immune response.

Depending on whether the production of antibodies depends on T cells or not

– Thymo-dependent antigens: are those against which the production of antibodies requires the help of T lymphocytes. This category is mainly represented by proteins.
– Thymo independent antigens: are those against which the production of antibodies does not require the help of T lymphocytes; such as polysaccharides and lipopolysacharides which are characterized by the presence of repetitive epitopes.

According to the chemical nature

 Protein antigens: these are the most immunogenic antigens. There are several types:
– Natural proteins: these are the main constituents of living things. They are encoded by corresponding genes.
– Artificial proteins: these are proteins whose natural core is on which side sequences are grafted.
– Synthetic proteins.

 Polysaccharide antigens: the immunogenic power of these antigens is weak. The simple polysaccharides have repetitive antigenic determinants which can activate B lymphocytes without resorting to T lymphocytes. The antigenic determinants of these antigens are sequential and nonconformational determinants, of approximately 6 sugars.

 Lipid antigens: lipids are not immunogenic. however, after their association with proteins, they can induce an immune response. They play the role of haptens. In certain diseases we find anti phospholipid antibodies.

 Nucleic acids: the immunogenicity of these substances is controversial when all attempts at immunization fail. However, immunization with nucleic acids associated with proteins induces the production of specific antibodies.

According to physical properties (solubility)

 Soluble antigens: constitute the majority of antigens in nature (proteins, polysaccharides, etc.)
 Particulate antigens: correspond to all particles, living or inert, which can induce an immune response (bacteria, virus, cell, parasite, etc.)

Applications

  1. vaccination
  2. serotherapy
  3. in vitro diagnosis
  4. skin tests
  5. desensitization

IMMUNOGLOBULINES

Our body has a defense system (immune system) ensuring its integrity.
It defends it against exogenous aggressions (microorganisms) and monitors pathological cell proliferation. To accomplish this task, it has natural (innate, non-specific) and other adaptive (acquired or specific) control mechanisms. The latter are provided by effectors which recognize antigens in a specific way.

What are immunoglobulines?

Immunoglobulins are serum glycoproteins from mammalian interstitial fluid that are produced by B cells (membrane immunoglobulin) or by plasma cells (soluble immunoglobulin). In general, it is produced following specific antigenic stimulation. Immunoglobulins produced after antigen stimulation or those having corresponding antigens are called ANTIBODIES.

CLASSES AND SUBCLASSES OF IMMUNOGLOBULINS

In mammals, there are five classes of immunoglobulins (IgG, IgM, IgA, IgE and IgD) which differ in their Phi, the half-life, the number of constant domains and the role of the constant parts. The classes and subclasses are terminated by the types of heavy chains; each of these chains is encoded by a different gene.

1/ Immunoglobulin G (IgG)

it is a glycoprotein made up of two heavy chains (γ) and two light chains (κ or λ). It represents 70 to 75% of total immunoglobulins with a concentration of 10 to 18 g / l. She
includes four subclasses: IgG1, IgG2, IgG3 and IgG4 and which represent 66%, 23%, 7% and 4% of IgG respectively. The difference between them lies in the hinge region and in the number of disulfide bridges.
Half of these immunoglobulins are 21 days, except for IgG3 which is 7 days. Their sedimentation constant is 7 S and with a PM of 146 Kd. IgG (1,2,3) fix the complement. Only IgG1 and IgG3 which can cross the placenta. The γ chain consists of 3 constant domains and a variable. But all light chains are only formed from two domains, a constant and a variable.

2/ Immunoglobulin A (IgA)

it is a glycoprotein in two forms, a monomeric form consisting of two heavy chains (α) and two light chains (κ or λ) and represents 80% of serum IgA. The second form is predominant in secretions (milk, saliva …). It is dimeric of 385 Kd and 11 S. it contains the chain J of 15 Kd plus a secretory component of 70 Kd. IgA groups two subclasses:
IgA1 which is found, above all, in serum form and IgA2 which is found, above all, in secretory form. The concentration of serum IgA is 1 to 4.5 g / 1. They do not fix the complement and do not cross the placenta. The α chain consists of 3 constant domains and a variable.

3/ Immunoglobuline M (IgM)

it is a glycoprotein of 900 Kd and 19 S. Usually, it is pentameric and made up of 10 heavy chains (μ) and 10 light chains (κ or λ) identical. It represents 10% of serum immunoglobulins. The subunits are linked together by disulfide bridges and the chain J (junction). The μ chain contains four constant domains and one variable. The membrane IgM is monomeric containing an additional hydrophobic sequence which allows it to anchor to the cytoplasmic membrane. This molecule constitutes the specific receptor for the antigen on the B lymphocyte (BCR). It is associated with two molecules Igα (CD79a) and Igβ (C79b) which are responsible for signal transduction after antigenic stimulation.

4/ Immunoglobulin D

it is a glycoprotein consisting of two heavy chains (δ) and two light chains q (κ or λ) identical. It represents 10% of serum Ig. It exists in two forms; the serum form which is soluble and the membrane form which constitutes, with the membrane IgM, the BCRs of mature B lymphocytes. It is the most sensitive to proteolysis.
The heavy chains δ only bind to each other by a disulfide bridge. It is 184 kd, 7 S and a half-life of 3 days. The serum concentration is 0.05 to 0.4 g / l. the heavy chain has three constant domains and one variable.

5/ Immunoglobulins E

it is 190 Kd and 8S glycoprotein with a half-life of 3 days. It consists of two heavy chains (ε) and two light chains (κ or λ). Its serum concentration is 0.003 g / l. Most IgE are found to be fixed on basophils and mast cells by receptors specific to the constant part (RFCεI). It does not fix the complement and does not cross the placenta. It is a thermolabile Ig.

ANTIGENIC PROPERTIES

an immunoglobulin can induce an adaptive immune response (production of antibodies). So it has the properties of an antigen. The antibodies produced are directed against the various antigenic determinants located on the constant part or the variable part. There are three groups of antigenic determinants of light chains or heavy chains defining the isotype, allotype and idiotype.

1- Isotype: it is the properties of antigenic determinants which define the classes and subclasses of immunoglobulins of the same species. It is carried by the constant part.

2 – Allotype: it is the properties of antigenic determinants which differentiate different individuals within the same species. It is carried by the constant part.

3 – Idiotype: it is the properties of antigenic determinants which differentiate immunoglobulins of the same isotype and of same allotype in an individual. It is carried by the variable part.

ORGANIC ROLES

An immunoglobulin molecule consists of a variable part, represented by the Fab fragment which constitutes the site of attachment of the antigen to the antibody; the latter is called the PARATOPE. So the variable part is responsible for the recognition of the antigen and the reaction with it. The constant party represented by the FC plays several roles:
(1) Activation of the complement (IgG1, IgG2, lgG3).
(2) binding to receptors carried by cells derived from the hematopoietic line (cytophilia or cytotropy).
IgG have three receptors: RFCγI or CD 64, RFCγII or CD 32 and RFCγIII or CD 16. They mainly fix IgG l and IgG 3. They are expressed by monocytes, macrophages, polynuclear, NK and CTL. IgEs have two receptors: RFCε I which is expressed by mast cells and basophils and RFCεII or CD23 which is expressed by the majority of blood cells (monocyte; polynuclear, lymphocytes, platelets …).
(3) the catabolism of immunoglobulins whose speed is regulated by Fc and more precisely by CH2.
(4) certain isotypes of immunoglobulins have the property of crossing cells (trans cytosis). IgA is secreted in exocrine secretions and IgG is secreted in the interstitial fluid.

IMMUNE RESPONSE

The first contact of the antigen With the organism activates the immune cells (T and B lymphocytes) and induces a primary immune response which is characterized by:

  • The latency phase lasts several days
  • The Ig level is slightly increased and then declines rapidly
  • The isotype is IgM

The second contact induces a secondary immune response which is characterized by:

  • The latency phase is very short
  • the Ig level is very high
  • the isotype is IgG especially with also IgA and IgM

Applications

Diagnostic:
-Search for soluble or particulate antigens (invitro)
-Immuno-scintigraphy (invivo)
-Serodiagnosis
Therapeutic:
-Serotherapy
-IGIV.